Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Toba Pulp Lestari Tbk (INRU) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Toba Pulp Lestari TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Toba Pulp Lestari Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Toba Pulp Lestari Tbk trades at Rp590 (market cap 826.39B, 34.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: Toba Pulp Lestari Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (635.5K versus 34.5K). Which is the better fit depends on your goals.

INRULABS
Market Cap
826.39B691.25B
Volume
34.5K635.5K
Lot
3456.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INRU
View details
LABS
View details

About Toba Pulp Lestari Tbk

PT Toba Pulp Lestari Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 329 dated April 26, 1983 of Misahardi Wilamarta, S.H., public notary in Jakarta.

Read more on INRU

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS